-+ 0.00%
-+ 0.00%
-+ 0.00%

Penumbra's THUNDERBOLT Gets FDA Clearance To Treat Acute Ischemic Stroke

Benzinga·06/11/2026 20:08:50
Listen to the news

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced it has received U.S. Food and Drug Administration (FDA) clearance for THUNDERBOLT™, expanding its computer assisted vacuum thrombectomy (CAVT™) technology to address acute ischemic stroke.